Prostaglandin receptor, a sub-family of cell surface seven-transmembrane receptors, are the G-protein-coupled receptors.Ten distinct prostaglandin receptors on different cell types are currently known. G-protein-coupled receptors are a subclass of cell surface seven-transmembrane receptors that prostaglandins bind to. The following are the names of these receptors: FP-FP, IP1-2-IP1, IP2 receptors, TP-TP receptor, EP1-4-EP1, EP2, EP3, and EP4 receptors. A class of lipid molecules known as prostaglandins, which are produced enzymatically from fatty acids and resemble hormones, play vital roles in the bodies of animals. Ten distinct prostaglandin receptors on different cell types are currently known.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V74470 | Selexipag-d7 | 1265295-21-3 | Selexipag-d7 is the deuterium labelled form of Selexipag. |
|
V5219 | Setipiprant （ACT-129968; KYTH-105) | 866460-33-5 | Setipiprant (ACT-129968 and KYTH-105) is a novel, potent, orally bioavailable and selective CRTH2 antagonist. |
|
V74459 | Sulprostone (Sulprostone; SHB 286; CP-34089; ZK-57671) | 60325-46-4 | Sulprostone (SHB 286) is a specific EP3 receptor agonist. |
|
V4395 | TAFLUPROST | 209860-87-7 | Tafluprost (formerly MK-2452; MK2452; AFP-168; Taflotan; Zioptan) is a prostaglandin (PG) analog used as ananti-glaucoma drug. |
|
V3782 | Taprenepag isopropyl | 1005549-94-9 | Taprenepag isopropyl (foremrly PF-04217329 or PF-4217329) is a prodrug of CP-544326 (Taprenepag) which is a potent and selective agonist of EP2 (prostaglandin EP receptor 2) with IC50 of 10nM and EC50 of 2.8nM. |
|
V74471 | Taprostene (CG-4203) | 108945-35-3 | Taprostene (CG-4203) is a synthetic, chemically stable analog of prostacyclin (PGI2). |
|
V3336 | Terutroban | 165538-40-9 | Terutroban (S18886; S-18886) is a selective TP (thromboxane-prostaglandin receptor) receptor antagonist with antiplatelet activity and the potential to be used for the secondary prevention of acute thrombotic complications. |
|
V3370 | TG4-155 | 1164462-05-8 | TG4-155 is a novel, potent and brain penetrant EP2 antagonist (KB = 2.4 nM) that is over 1000-fold less effective at EP4 (KB = 11.4 µM) and a panel of other receptors and channels. |
|
V28667 | Timapiprant sodium (OC000459) | 950688-14-9 | Timapiprant sodium (OC000459 sodium) is a potent, selective, and orally bioavailable D prostanoid receptor 2 (DP2, formerly known as CRTH2) antagonist with IC50 of 13 nM. |
|
V74487 | TP-16 | 2332972-26-4 | TP-16 is a new selective EP4 antagonist (inhibitor) with IC50 of 2.1nm. |
|
V74481 | trans-Isoferulic acid-d3 | 1028203-97-5 | trans-Isoferulic acid-d3 is the deuterated form of trans-Isoferulic acid. |
|
V4396 | TRAVOPROST | 157283-68-6 | Travoprost (also known as Fluprostenol isopropyl ester; AL6221; Flu-Ipr; brand name Travatan) is medication used to treat high pressure inside the eye including glaucoma. |
|
V4134 | Treprostinil (LRX-15) | 81846-19-7 | Treprostinil (LRX-15; trade names: Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation), a synthetic analog of prostacyclin (PGI2), is a novel and potent DP1 and EP2 agonist with EC50 values of 0.6±0.1 and 6.2±1.2 nM, respectively. |
|
V74473 | Treprostinil palmitil (INS-1009) | 1706528-83-7 | Treprostinil palmitil (TP) is the precursor of Treprostinil (UT-15), a potent DP1 and EP2 agonist/activator with EC50s of 0.6±0.1 and 6.2±1.2 nM, respectively. |
|
V4135 | Treprostinil sodium (LRX15) | 289480-64-4 | Treprostinil sodium (LRX-15; Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation), a synthetic analog of prostacyclin (PGI2), is a novel and potent DP1 and EP2 agonist with EC50 values of 0.6±0.1 and 6.2±1.2 nM, respectively. |
|
V74483 | Vorbipiprant (CR6086) | 1417742-86-9 | Vorbipiprant (CR6086) is an EP4 receptor antagonist that works as a targeted immunomodulator. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
